| Автор | Soohoo, Nelson |
| Автор | Schneider, Jerry, A. |
| Автор | Kaplan, Robert, M. |
| Дата выпуска | 1997 |
| dc.description | Objective. Cysteamine is a recently licensed orphan drug used to treat the inherited metabolic disease cystinosis. The drug delays the onset of renal failure in cystinotic patients and may provide many other significant health benefits. This study examined the cost-effectiveness of the administration of cysteamine to cystinotic patients prior to end-stage renal disease (ESRD). Method. Decision-tree analysis and cost-effectiveness analysis. Cost data were estimated from current clinical charges and Medicare public-access reports. Life expectancy outcomes were derived from both published and unpublished clinical studies and from the U.S. Renal Data System. Results. Cysteamine therapy can extend the life of kidneys and delay renal transplantation, thereby increasing life expectancy for patients with cystinosis. Patients receiving cysteamine therapy prior to renal failure have lifetime-treatment drug costs of $234,000, in comparison with $238,000 for those who are not medicated. Costs of cysteamine therapy are offset by savings associated with delaying transplantation and costs of dialysis. Conclusions. Use of the orphan drug cysteamine both improves health outcomes and reduces health care costs for patients with cystinosis. Key words: cystinosis; cysteamine ; decision analysis; cost-effectiveness. (Med Decis Making 1997;17:193-198) |
| Издатель | Sage Publications |
| Название | A Cost-Effectiveness Analysis of the Orphan Drug Cysteamine in the Treatment of Infantile Cystinosis |
| Тип | Journal Article |
| DOI | 10.1177/0272989X9701700210 |
| Print ISSN | 0272-989X |
| Журнал | Medical Decision Making |
| Том | 17 |
| Первая страница | 193 |
| Последняя страница | 198 |
| Выпуск | 2 |
| Библиографическая ссылка | Gahl WA, Renlund M, Thoene JG.Lysosomal transport disorders: cystinosis and sialic acid storage disorders . In Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic Basis of Inherited Disease New York, McGraw-Hill, 1989, pp 2619-47. |
| Библиографическая ссылка | Schneider JA, Katz B, Melles RB.Cystinosis . AKF Neph Letter 1990;7 22-31. |
| Библиографическая ссылка | Gretz N, Manz F, Augustin R, et al. Survival time in cystinosis A collaborative studyProc Eur Dial Transplant Assoc1983, 19:582-9 |
| Библиографическая ссылка | Chan AM, Lynch MJ, Bailey JD, Ezrin C, Fraser D.Hypothyroidism in cystinosis A clinical, endocrinologic and histologic study involving sixteen patients with cystinosis. Am J Med.1970;48:678-92 |
| Библиографическая ссылка | Gahl WA, Schneider JA, Thoene JG, Chesney R.Course of nephropathic cystinosis after age 10 years. J Pediatr. 1986; 109:605-8. |
| Библиографическая ссылка | Garner TI, Dardis R.Cost-effectiveness analysis of end-stage renal disease treatments. Med Care. 1987;25:25-34. |
| Библиографическая ссылка | Broyer M, Tete MJ, Gubler MC.Late symptoms in infantile cystinosis. Pediatr Nephrol. 1987;1:519-24. |
| Библиографическая ссылка | Burki E.Uber die Cystinkrankheit in Kleinkindersalter unter besonderer Berucksichtigung des Augenbefundes. Ophthalmologica, 1941;101:257 |
| Библиографическая ссылка | Fivush B, Breen OC, Porter CC, Balfe JW, O'Regan S, Gahl WA.Pancreatic endocrine insufficiency in posttransplant cystinosisAm J Dis Child. 1987;141:1087-9. |
| Библиографическая ссылка | Fivush B, Flick JA, Gahl WA.Pancreatic exocrine insufficiency in a patient with nephropathic cystinosis. J Pediatr. 1988;112:49-51. |
| Библиографическая ссылка | Ehrich JH, Wolff G, Stoeppler L, Heyer R, Offner G, Brodehl J.Psychosocial intellectual development of children with infantile cystinosis and cerebral atrophy [author's transl] . Klin Padiatr. 1979;191:483-92. |
| Библиографическая ссылка | Cochat P, Drachman R, Gagnadoux MF, Pariente D, Broyer M.Cerebral atrophy and nephropathic cystinosis. Arch Dis Child.1986;61:401-3. |
| Библиографическая ссылка | Jonas AJ, Conley SB, Marshall R, Johnson RA, Marks M, Rosenberg H.Nephropathic cystinosis with central nervous system involvement. Am J Med.1987;83:966-70. |
| Библиографическая ссылка | Gahl WA, Kaiser-Kupfer MI.Complications of nephropathic cystinosis after renal failure. Pediatr Nephrol. 1987 ;1.260-8. |
| Библиографическая ссылка | Trauner DA, Chase C, Scheller J, Katz B, Schneider JANeurologic and cognitive deficits in children with cystinosisJ Pediatr. 1988;112:912-4. |
| Библиографическая ссылка | Fink JK, Brouwers P, Barton N, et al. Neurologic complications in long-standing nephropathic cystinosis . Arch Neurol 1989,46:543-8. |
| Библиографическая ссылка | Gahl WA, Dalakas MC, Charnas L, et al. Myopathy and cystine storage in muscles in a patient with nephropathic cystinosis . N Engl J Med. 1988;319:1461-4. |
| Библиографическая ссылка | Charnas LR, Luciano CA, Dalakas M, et al. Distal vacuolar myopathy in nephropathic cystinosis. Ann Neurol . 1994;35: 181-8. |
| Библиографическая ссылка | Cystinosis Collaborative Research Group: Linkage of the gene for cystinosis to markers on the short arm of chromosome 17. Nat Genet. 1995;10:246-8. |
| Библиографическая ссылка | Jean G, Fuchshuber A, Town MM, et al. High-resolution mapping of the gene for cystinosis, using combined biochemical and linkage analysis. Am J Hum Genet1996;58: 535-43. |
| Библиографическая ссылка | Thoene JG, Oshima RG, Crawhall JC, Olson DL, Schneider JA.Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo. J Clin Invest1976;58:180-9. |
| Библиографическая ссылка | Pisoni RL, Thoene JG, Christensen HN.Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts. J Biol Chem.1985;260:4791-8. |
| Библиографическая ссылка | Gahl WA, Reed GF, Thoene JG, et al. Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med. 1987; 316:971-7. |
| Библиографическая ссылка | Markello TC, Bernardini IM, Gahl WA.Improved renal function in children with cystinosis treated with cysteamine . N Engl J Med. 1993;328:1157-62. |
| Библиографическая ссылка | Gahl WA, Charnas L, Markello TC, Bernardini I, Ishak KG, Dalakas MC.Parenchymal organ cystine depletion with long-term cysteamine therapy. Biochem Med Metab Biol1992;48: 275-85. |
| Библиографическая ссылка | Stange PV, Sumner AT.Predicting treatment costs and life expectancy for end-stage renal disease. N Engl J Med. 1978; 298:372-8. |
| Библиографическая ссылка | USRDS 1990 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1990. |
| Библиографическая ссылка | Levinsky NG, Rettig RA.The Medicare end-stage renal disease program. A report from the Institute of Medicine. N Engl J Med. 1991;324:1143-8. |
| Библиографическая ссылка | Weinstein MC, Stason WB.Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296:716-21. |
| Библиографическая ссылка | Clark KF, Franklin PS, Reisch JS, et al. Effect of cysteamine-HCl and phosphocysteamine dosage on renal function and growth in children with nephropathic cystinosis (abstr. Pediatr Res.1992,31:331A. |
| Библиографическая ссылка | Schneider JA.Unpublished , 1992 |
| Библиографическая ссылка | Broyer M.Kidney transplantation in children—data from the EDTA registry. Transplant Proc. 1989;21:1985-8. |
| Библиографическая ссылка | Weinstein MC, Coley CM, Richter JM.Medical management of gallstones: a cost-effectiveness analysis. J Gen Intern Med. 1990;5:277-84. |
| Библиографическая ссылка | Hagen MD.Decision analysis: a review. Fam Med. 1992;24. 349-54. |
| Библиографическая ссылка | Kaplan RM.Quality of life assessment for cost/utility studies in cancer. Cancer Treatment Rev.1993;19(suppl A):85-96. |
| Библиографическая ссылка | Ehrich JHH, Brodehl J, Byrd DI, et al. Renal transplantation in 22 children with nephropathic cystinosis . Pediatr Nephrol. 1991:5:707-14. |
